Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor

被引：0
|
作者：
Sayaka Misaki
Satoshi Murata
Miyuki Shimoji
Takayasu Iwai
Andreas Michael Sihombing
Ken Aoki
Yutaka Takahashi
Yoshiyuki Watanabe
机构：
[1] Shiga University of Medical Science,Department of Radiology
[2] Shiga University of Medical Science Hospital,Cancer Center
[3] Shiga University of Medical Science,Department of Surgery
[4] Osaka University Graduate School of Medicine,Department of Medical Physics and Engineering
来源：
Japanese Journal of Radiology | 2022年 / 40卷
关键词：
Radioimmunotherapy; Tumor antigen-specific CD8-positive T-lymphocyte; Cytotoxic T-lymphocyte; Immune checkpoint inhibitor; Abscopal effect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1307 / 1315
页数：8
相关论文
共 50 条
  • [21] Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response
    Ahmed, Kazi Mokim
    Veeramachaneni, Ratna
    Deng, Defeng
    Putluri, Nagireddy
    Putluri, Vasanta
    Cardenas, Maria F.
    Wheeler, David A.
    Decker, William K.
    Frederick, Andy, I
    Kazi, Sawad
    Sikora, Andrew G.
    Sandulache, Vlad C.
    Frederick, Mitchell J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [22] Modelling of Immune Checkpoint Network Explains Synergistic Effects of Combined Immune Checkpoint Inhibitor Therapy and the Impact of Cytokines in Patient Response
    Kondratova, Maria
    Barillot, Emmanuel
    Zinovyev, Andrei
    Calzone, Laurence
    CANCERS, 2020, 12 (12) : 1 - 19
  • [23] Radiation enhanced the local and distant antitumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma
    Takahashi, Yutaka
    Yasui, Tomohiro
    Tamari, Keisuke
    Minami, Kazumasa
    Otani, Keisuke
    Isohashi, Fumiaki
    Seo, Yuji
    Kambe, Ryosuke
    Koizumi, Masahiko
    Ogawa, Kazuhiko
    PLOS ONE, 2017, 12 (12):
  • [24] Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study
    Caiyun Nie
    Weifeng Xu
    Yanwei Guo
    Xiaohui Gao
    Huifang Lv
    Beibei Chen
    Jianzheng Wang
    Yingjun Liu
    Jing Zhao
    Saiqi Wang
    Yunduan He
    Xiaobing Chen
    BMC Cancer, 23
  • [25] Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study
    Nie, Caiyun
    Xu, Weifeng
    Guo, Yanwei
    Gao, Xiaohui
    Lv, Huifang
    Chen, Beibei
    Wang, Jianzheng
    Liu, Yingjun
    Zhao, Jing
    Wang, Saiqi
    He, Yunduan
    Chen, Xiaobing
    BMC CANCER, 2023, 23 (01)
  • [26] Response to subsequent therapy after dual immune checkpoint blockade in metastatic breast cancer
    Shah, A. N.
    Yalamanchili, A.
    Helenowski, I.
    Bhole, S.
    Woodman, J.
    Gradishar, W. J.
    Cristofanilli, M.
    Santa-Maria, C. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [27] Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model
    Yonezawa, Noritaka
    Murakami, Hideki
    Demura, Satoru
    Kato, Satoshi
    Miwa, Shinji
    Yoshioka, Katsuhito
    Shinmura, Kazuya
    Yokogawa, Noriaki
    Shimizu, Takaki
    Oku, Norihiro
    Kitagawa, Ryo
    Handa, Makoto
    Annen, Ryohei
    Kurokawa, Yuki
    Fushimi, Kazumi
    Mizukoshi, Eishiro
    Tsuchiya, Hiroyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 15
  • [28] Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma A case report
    Langan, Ewan A.
    Budner, Kaja
    Zillikens, Detlef
    Terheyden, Patrick
    MEDICINE, 2021, 100 (16) : E25513
  • [29] Impact of sequencing of immune checkpoint blockade and targeted radionuclide therapy on murine tumor response
    Kerr, Caroline P.
    Grudzinski, Joseph J.
    Ferreira, Carolina A.
    Adam, David
    Sheehan-Klenk, Julia
    Bates, Amber M.
    Jin, Won Jong
    Kwon, Ohyun
    Jagodinsky, Justin C.
    Powers, Maria
    Sriramaneni, Raghava N.
    Clark, Paul A.
    Zangl, Luke
    Thanh Phuong T. Nguyen
    Pinchuk, Anatoly N.
    Choi, Cynthia
    Massey, Christopher F.
    Hernandez, Reinier
    Bednarz, Bryan
    Weichert, Jamey P.
    Morris, Zachary S.
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression
    Pierini, Stefano
    Mishra, Abhishek
    Perales-Linares, Renzo
    Uribe-Herranz, Mireia
    Beghi, Silvia
    Giglio, Andrea
    Pustylnikov, Sergei
    Costabile, Francesca
    Rafail, Stavros
    Amici, Augusto
    Facciponte, John G.
    Koumenis, Costantinos
    Facciabene, Andrea
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
12345